echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > [Cell Sub-Journal] New targets for pancreatic cancer microbiome and immune regulation!

    [Cell Sub-Journal] New targets for pancreatic cancer microbiome and immune regulation!

    • Last Update: 2022-08-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    This article is original from Translational Medicine Network, please indicate the source for reprinting 

    Author: TMZHI

    Introduction: Different from other solid tumors, the stromal component of pancreatic cancer accounts for more than 80% of the tumor volume, including abundant extracellular matrix, pancreatic stellate cells, and tumor-associated fibroblasts


    On August 8, Anderson Cancer Center published a research article titled: "Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer" in "Cancer Cell", revealing that The Col1 homotrimer-α3β1 integrin signaling axis is a cancer-specific therapeutic target


    Doi: 10.


    Research Background

     01 

    During the occurrence and development of pancreatic cancer, a matrix-rich and highly immunosuppressive microenvironment is formed by the interaction of tumor cells, immune cells, stromal cells and extracellular matrix.



    Collagen type I (Col1), the most abundant protein in the human body, widely accumulates in the microenvironment of pancreatic ductal adenocarcinoma (PDAC), and is heterologous to normal collagen type I (Col1) produced by fibroblasts in the microenvironment Compared with trimers (α1/α2/α1), pancreatic cancer cells can specifically produce unique Col1 homotrimers (α1/α1/α1), however, the production of Col1 by pancreatic cancer cells has a negative impact on pancreatic cancer tumor biology.


    Biological functions of Col1 homotrimers

     02 

    The researchers constructed the spontaneous tumorigenic model mice of pancreatic cancer with the conditional knockout of Col1 homotrimer, and found that after knocking out the Col1 homotrimer, the survival of spontaneous pancreatic cancer mice was significantly prolonged, and the pancreatic tumor burden was significantly reduced.


    Figure 1.


     03 

    Using transcriptomics, we found that Col1 homotrimers significantly up-regulated proliferation-related pathways such as glutathione metabolism, DNA replication, RNA splicing, and cell cycle, which were dependent on integrin α3β1 (Figure 2)


    Figure 2.


    Deletion of Col1 homotrimers

     04 

    Using microbiome sequencing and intratumoral immune cell profiling, we found that loss of Col1 homotrimers preserved gut microbiota homeostasis in mice with pancreatic cancer (Fig.


    Figure 3.


    Significance

     05 

    This study demonstrates that cancer cell-derived oncogenic Col1 homotrimers also influence the tumor immune microenvironment to promote immunosuppression, establishes that this immune regulation is associated with a unique intratumoral microbiome, and develops new tools that can be used in the microbiome and immune system.


    References:


    This article is intended to introduce the progress of medical research and cannot be used as a reference for treatment plans


    Recommended · Live/Event

    September 15-16 09:00-17:30 Chongqing

    The First Southwest Single Cell Omics Technology Application Forum

    Scan the code to participate for free

    October 14-16 09:00-17:30 Shanghai

    The 4th Shanghai International Cancer Congress

    Scan the code to participate

    November 10-11 09:00-17:30 Shanghai

    The 5th Symposium on Modern Clinical Molecular Diagnosis

    Scan the code to participate for free

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.